MOHANA NAIDU: Open Payments
NPI 1861561292 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 40 payments from 16 companies in 2025. Trend: 2023 $752 · 2024 $820 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $153 |
| Vanda Pharmaceuticals Inc. | 5 | $128 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| Tris Pharma Inc | 4 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $70 |
| Lundbeck LLC | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
Products named: VRAYLAR, HETLIOZ, COBENFY, Dyanavel XR, AUSTEDO XR, REXULTI, INGREZZA, CAPLYTA.
Industry payments across IL — which companies pay providers there.
